These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8009608)

  • 1. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients.
    John GT; Thomas PP; Thomas M; Jeyaseelan L; Jacob CK; Shastry JC
    Transplantation; 1994 Jun; 57(11):1683-4. PubMed ID: 8009608
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients.
    Lui SL; Li FK; Choy BY; Chan TM; Lo WK; Lai KN
    Transpl Infect Dis; 2004 Mar; 6(1):55-6. PubMed ID: 15225230
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a place for prophylaxis against tuberculosis following renal transplantation?
    Naqvi SA; Hussain M; Askari H; Hashmi A; Hussain Z; Hussain I; Hafiz S; Yazdani I; Rizvi SA
    Transplant Proc; 1992 Oct; 24(5):1912. PubMed ID: 1412909
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.
    Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K
    Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ; Ynares C; Dummer JS
    Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial.
    Serón D; Oppenheimer F; Pallardó LM; Lauzurica R; Errasti P; Gomez-Huertas E; Bosmans JL; Sanchez-Plumed J; Romero R; Marques M; Fulladosa X; Moreso F
    Transplantation; 2008 Jul; 86(1):82-7. PubMed ID: 18622282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
    Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
    Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IUAT trial on isoniazid preventive treatment in persons with fibrotic lung lesions.
    Krebs A
    Bull Int Union Tuberc; 1976; 51(1):193-201. PubMed ID: 801115
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for tuberculosis in the study of the living renal donor in a developing country.
    Hernández-Hernández E; Alberú J; González-Michaca L; Bobadilla-del Valle M; Quiroz-Mejía RA; Baizabal-Olarte R; Correa-Rotter R; Sifuentes-Osornio J
    Transplantation; 2006 Jan; 81(2):290-2. PubMed ID: 16436975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
    Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of isoniazid prophylaxis in renal allograft recipients.
    Naqvi R; Akhtar S; Noor H; Saeed T; Bhatti S; Sheikh R; Ahmed E; Akhtar F; Naqvi A; Rizvi A
    Transplant Proc; 2006 Sep; 38(7):2057-8. PubMed ID: 16979998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients.
    Kumar D; Rotstein C; Miyata G; Arlen D; Humar A
    J Infect Dis; 2003 May; 187(10):1639-45. PubMed ID: 12721944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of tuberculosis in renal transplant patients.
    Park SB; Joo I; Park YI; Suk J; Cho WH; Park CH; Kim HC
    Transplant Proc; 1996 Jun; 28(3):1520-2. PubMed ID: 8658768
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.
    Massari PU; Grosso S; de Boccardo G; Vásquez MC; Schiavelli RO; Sabbatiello RR; Casadei DH; Rial MC; Jost LJ; Túrin MD; Agost Carreño C A; Maggiora EC; Gadea MM
    Transplant Proc; 1996 Dec; 28(6):3365-7. PubMed ID: 8962310
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.
    Singh N; Wagener MM; Gayowski T
    Transplantation; 2002 Sep; 74(6):892-5. PubMed ID: 12364876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double-blind, placebo-controlled, crossover trial.
    Sharma RK; Prasad N; Gupta A; Kapoor R
    Am J Kidney Dis; 2006 Jul; 48(1):128-33. PubMed ID: 16797395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of vardenafil for kidney transplant recipients with erectile dysfunction].
    Yang J; Ju W; Zeng FQ; Xiao YJ; Zhang XP; Xiao CG
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):911-3. PubMed ID: 19157102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in kidney transplant recipients and patients on hemodialysis: a comparison with healthy individuals.
    Nouri-Majalan N; Sanadgol H; Rahimian M; Soleimani H
    Iran J Kidney Dis; 2008 Jul; 2(3):154-9. PubMed ID: 19377230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.